Pharmacodynamic and pharmacokinetic factors in a case of neuroleptic malignant syndrome

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical psychopharmacology 1998-08, Vol.18 (4), p.346-347
Hauptverfasser:	Shad, M U, Preskorn, S H
Format:	Artikel
Sprache:	eng
Schlagworte:	Antipsychotic Agents - administration & dosage Antipsychotic Agents - adverse effects Antipsychotic Agents - pharmacokinetics Brain - drug effects Drug Interactions Drug Therapy, Combination Humans Lithium Carbonate - administration & dosage Lithium Carbonate - adverse effects Lithium Carbonate - pharmacokinetics Neuroleptic Malignant Syndrome - blood Neuroleptic Malignant Syndrome - diagnosis Paroxetine - administration & dosage Paroxetine - adverse effects Paroxetine - pharmacokinetics Perphenazine - administration & dosage Perphenazine - adverse effects Perphenazine - pharmacokinetics Serotonin Uptake Inhibitors - administration & dosage Serotonin Uptake Inhibitors - adverse effects Serotonin Uptake Inhibitors - pharmacokinetics Trazodone - administration & dosage Trazodone - adverse effects Trazodone - pharmacokinetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!